AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 32635494 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise + OCX 1 (2.55 mg/day)
Number of subjects: 14
Study 32635494 — intervention group
Group type: COMPARATOR
Intervention: Control (no exercise and placebo)
Number of subjects: 14
Study 32635494 — intervention group
Group type: COMPARATOR
Intervention: Exercise (E)
Number of subjects: 14
Study 35690859 — intervention group
Group type: EXPERIMENTAL
Intervention: Machine learning model using plasma cfDNA fragmentomics
Number of subjects: 1214
Study 34186531 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive Behavioral Therapy (CBT)
Number of subjects: 28
Study 34186531 — intervention group
Group type: COMPARATOR
Intervention: Treatment as Usual (TAU)
Number of subjects: 28
Study 34186531 — intervention group
Group type: COMPARATOR
Intervention: Ketamine (6 intravenous infusions over 3 weeks)
Number of subjects: 28
Study 35730553 — intervention group
Group type: EXPERIMENTAL
Intervention: Bright light (1300 lux) during wakefulness
Number of subjects: 8
Study 35730553 — intervention group
Group type: COMPARATOR
Intervention: Dim light (6 lux) during wakefulness
Number of subjects: 8
Study 33791829 — intervention group
Group type: COMPARATOR
Intervention: Atorvastatin 80 mg alone
Number of subjects: 12
Study 33791829 — intervention group
Group type: EXPERIMENTAL
Intervention: Atorvastatin 80 mg plus FDCSL (400/90 mg)
Number of subjects: 12
Study 33791829 — intervention group
Group type: COMPARATOR
Intervention: FDCSL (400/90 mg) alone
Number of subjects: 12
Study 32910912 — intervention group
Group type: EXPERIMENTAL
Intervention: Deltamethrin-impregnated collars for dogs
Number of subjects: 6922
Study 32910912 — intervention group
Group type: EXPERIMENTAL
Intervention: Praziquantel for dog deworming
Number of subjects: 6922
Study 32910912 — intervention group
Group type: EXPERIMENTAL
Intervention: Health education campaigns
Number of subjects: 6922
Study 32910912 — intervention group
Group type: EXPERIMENTAL
Intervention: Canine rabies vaccination
Number of subjects: 6922
Study 35674708 — intervention group
Group type: COMPARATOR
Intervention: Mobile information communication technology devices and applications
Number of subjects: 16
Study 35674708 — intervention group
Group type: EXPERIMENTAL
Intervention: Telehealth program for promoting patient self‐management
Number of subjects: 16
Study 35674708 — intervention group
Group type: EXPERIMENTAL
Intervention: Structured rehabilitation with mobile self‐monitoring
Number of subjects: 16
Study 34185550 — intervention group
Group type: EXPERIMENTAL
Intervention: Meditation-Based Lifestyle Modification (MBLM)
Number of subjects: 12
Study 32810088 — intervention group
Group type: EXPERIMENTAL
Intervention: Oxytocin infusion (30 units in 1000ml normal saline at 15 units/hour during surgery)
Number of subjects: 60
Study 32810088 — intervention group
Group type: COMPARATOR
Intervention: Normal saline (control group)
Number of subjects: 60
Study 32810088 — intervention group
Group type: EXPERIMENTAL
Intervention: Oxytocin infusion
Number of subjects: 60
Study 34412546 — intervention group
Group type: EXPERIMENTAL
Intervention: Patient-centered communication style (PC group)
Number of subjects: 120
Study 34412546 — intervention group
Group type: EXPERIMENTAL
Intervention: Doctor-centered communication style (DC group)
Number of subjects: 120
Study 34412546 — intervention group
Group type: COMPARATOR
Intervention: No consultation (control group)
Number of subjects: 120
Study 32791086 — intervention group
Group type: EXPERIMENTAL
Intervention: Cyclosporine
Number of subjects: 138
Study 32791086 — intervention group
Group type: COMPARATOR
Intervention: Mycophenolate mofetil plus dexamethasone
Number of subjects: 138
Study 33959169 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin D supplementation (50,000 U weekly for 6 weeks followed by 1000 U daily for deficiency; 1000 U daily for insufficiency)
Number of subjects: 132
Study 33959169 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin D supplementation
Number of subjects: 132
Study 33959169 — intervention group
Group type: COMPARATOR
Intervention: Placebo (control group)
Number of subjects: 132
Study 35918547 — intervention group
Group type: EXPERIMENTAL
Intervention: Haptic simulator training
Number of subjects: 36
Study 35918547 — intervention group
Group type: COMPARATOR
Intervention: Non-haptic simulator training
Number of subjects: 36
Study 33607244 — intervention group
Group type: EXPERIMENTAL
Intervention: Mediation analyses of health interventions
Number of subjects: 0
Study 33607244 — intervention group
Group type: EXPERIMENTAL
Intervention: Published mediation analysis of the Systolic Blood Pressure Intervention Trial (SPRINT)
Number of subjects: 0
Study 35484491 — intervention group
Group type: EXPERIMENTAL
Intervention: Electronic recruitment strategies (email communication, synchronous video presentations)
Number of subjects: 45
Study 35484491 — intervention group
Group type: EXPERIMENTAL
Intervention: Email communication from clinic leaders
Number of subjects: 45
Study 35484491 — intervention group
Group type: EXPERIMENTAL
Intervention: Synchronous video presentations
Number of subjects: 45
Study 35484491 — intervention group
Group type: EXPERIMENTAL
Intervention: Recruitment costs
Number of subjects: 45
Study 35484491 — intervention group
Group type: EXPERIMENTAL
Intervention: Challenges faced
Number of subjects: 45
Study 34847908 — intervention group
Group type: EXPERIMENTAL
Intervention: IMARA‐SA
Number of subjects: 60
Study 34847908 — intervention group
Group type: COMPARATOR
Intervention: Health promotion control program
Number of subjects: 60
Study 34128999 — intervention group
Group type: EXPERIMENTAL
Intervention: Eptinezumab, 100 mg
Number of subjects: 480
Study 34128999 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 480
Study 32825817 — intervention group
Group type: EXPERIMENTAL
Intervention: Goal-directed lactated Ringer's solution (crystalloid)
Number of subjects: 120
Study 32825817 — intervention group
Group type: COMPARATOR
Intervention: Hydroxyethyl starch 6% 130/0.4 (colloid)
Number of subjects: 120
Study 34608092 — intervention group
Group type: EXPERIMENTAL
Intervention: Resilient Hyaluronic Acid Redensity (RHAR) filler
Number of subjects: 0
Study 34608092 — intervention group
Group type: COMPARATOR
Intervention: No-treatment control
Number of subjects: 0
Study 33030563 — intervention group
Group type: EXPERIMENTAL
Intervention: MK-7 (375 μg daily)
Number of subjects: 142
Study 33030563 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 142
Study 33051943 — intervention group
Group type: EXPERIMENTAL
Intervention: Solriamfetol
Number of subjects: 0
Study 34581941 — intervention group
Group type: EXPERIMENTAL
Intervention: Auriculotherapy
Number of subjects: 166
Study 34581941 — intervention group
Group type: COMPARATOR
Intervention: Routine care
Number of subjects: 166
Study 32947017 — intervention group
Group type: EXPERIMENTAL
Intervention: Palliative Care (PC) cohort
Number of subjects: 2983
Study 32947017 — intervention group
Group type: COMPARATOR
Intervention: Regional comparison cohort
Number of subjects: 2983
Study 32947017 — intervention group
Group type: COMPARATOR
Intervention: Two-state comparison cohort
Number of subjects: 2983
Study 32947017 — intervention group
Group type: COMPARATOR
Intervention: Eight-state comparison cohort
Number of subjects: 2983
Study 33536005 — intervention group
Group type: EXPERIMENTAL
Intervention: AGLR > 90
Number of subjects: 495
Study 33536005 — intervention group
Group type: COMPARATOR
Intervention: AGLR ≤ 90
Number of subjects: 495
Study 33536005 — intervention group
Group type: EXPERIMENTAL
Intervention: AGLR
Number of subjects: 495
Study 36367386 — intervention group
Group type: EXPERIMENTAL
Intervention: Nitrate-rich beetroot juice
Number of subjects: 27
Study 36367386 — intervention group
Group type: COMPARATOR
Intervention: Nitrate-depleted beetroot juice (placebo)
Number of subjects: 27
Study 34115035 — intervention group
Group type: EXPERIMENTAL
Intervention: Cold Snare Polypectomy (CSP)
Number of subjects: 119
Study 34115035 — intervention group
Group type: COMPARATOR
Intervention: Hot Snare Polypectomy (HSP)
Number of subjects: 119
Study 32335086 — intervention group
Group type: EXPERIMENTAL
Intervention: Periprostatic block
Number of subjects: 90
Study 32335086 — intervention group
Group type: EXPERIMENTAL
Intervention: Periapical triangle block
Number of subjects: 90
Study 32335086 — intervention group
Group type: EXPERIMENTAL
Intervention: Branches of perineal nerve (BPN) block
Number of subjects: 90
Study 35761355 — intervention group
Group type: EXPERIMENTAL
Intervention: Cervical Collar (CC)
Number of subjects: 32
Study 35761355 — intervention group
Group type: COMPARATOR
Intervention: Manual In-line Stabilization (MILS)
Number of subjects: 32
Study 34514891 — intervention group
Group type: COMPARATOR
Intervention: Group A: manual lymphatic drainage + Intermittent Pneumatic Compression + Bandages
Number of subjects: 194
Study 34514891 — intervention group
Group type: EXPERIMENTAL
Intervention: Group B: pneumatic lymphatic drainage + Intermittent Pneumatic Compression + Bandages
Number of subjects: 194
Study 34514891 — intervention group
Group type: EXPERIMENTAL
Intervention: Group C: only Intermittent Pneumatic Compression + Bandages
Number of subjects: 194
Study 34839318 — intervention group
Group type: EXPERIMENTAL
Intervention: Sugammadex (2 mg/kg administered after rocuronium infusion)
Number of subjects: 76
Study 34839318 — intervention group
Group type: COMPARATOR
Intervention: Control (no neuromuscular blockade after induction of anesthesia)
Number of subjects: 76
Study 34839318 — intervention group
Group type: EXPERIMENTAL
Intervention: Sugammadex
Number of subjects: 76
Study 34454860 — intervention group
Group type: EXPERIMENTAL
Intervention: Selective intracoronary hypothermia during PPCI
Number of subjects: 50
Study 34454860 — intervention group
Group type: COMPARATOR
Intervention: Standard PPCI (Control)
Number of subjects: 50
Study 35633928 — intervention group
Group type: EXPERIMENTAL
Intervention: BPNN model
Number of subjects: 355
Study 35633928 — intervention group
Group type: EXPERIMENTAL
Intervention: SVM model
Number of subjects: 355
Study 33434277 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients with co-morbidities
Number of subjects: 379
Study 36052811 — intervention group
Group type: EXPERIMENTAL
Intervention: Decision aid plus telephone coaching (intervention)
Number of subjects: 800
Study 36052811 — intervention group
Group type: COMPARATOR
Intervention: Usual care (control)
Number of subjects: 800
Study 33493368 — intervention group
Group type: EXPERIMENTAL
Intervention: SYN023 (0.3 mg/kg, 1.0 mg/kg, 2.0 mg/kg) via intramuscular injection
Number of subjects: 50
Study 33493368 — intervention group
Group type: EXPERIMENTAL
Intervention: SYN023 (0.3 mg/kg) via subcutaneous injection
Number of subjects: 50
Study 33493368 — intervention group
Group type: EXPERIMENTAL
Intervention: SYN023 (0.3 mg/kg) via intramuscular or subcutaneous injection
Number of subjects: 50
Study 33493368 — intervention group
Group type: EXPERIMENTAL
Intervention: SYN023 (higher doses)
Number of subjects: 50
Study 33493368 — intervention group
Group type: EXPERIMENTAL
Intervention: SYN023 (0.3 mg/kg)
Number of subjects: 50
Study 33493368 — intervention group
Group type: COMPARATOR
Intervention: SYN023 (IM vs SC administration)
Number of subjects: 50
Study 32432384 — intervention group
Group type: EXPERIMENTAL
Intervention: Multi-session CBM-I (Sentence Word Association Paradigm [SWAP] with feedback)
Number of subjects: 318
Study 32432384 — intervention group
Group type: COMPARATOR
Intervention: Control (SWAP without feedback)
Number of subjects: 318
Study 32432384 — intervention group
Group type: COMPARATOR
Intervention: Waitlist condition
Number of subjects: 318
Study 35113430 — intervention group
Group type: EXPERIMENTAL
Intervention: Moderate-Intensity Intermittent Training (MIT)
Number of subjects: 15
Study 35113430 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-Intensity Continuous Training (LCT)
Number of subjects: 15
Study 34507697 — intervention group
Group type: EXPERIMENTAL
Intervention: Autologous platelet rich plasma
Number of subjects: 0
Study 34932988 — intervention group
Group type: EXPERIMENTAL
Intervention: Nomogram for predicting sarcopenia risk
Number of subjects: 1050
Study 35956389 — intervention group
Group type: EXPERIMENTAL
Intervention: Chitosan-derived glucosamine (1500 mg glucosamine sulfate 2KCl)
Number of subjects: 0
Study 35956389 — intervention group
Group type: EXPERIMENTAL
Intervention: Biofermentation-derived glucosamine (1500 mg glucosamine sulfate 2KCl)
Number of subjects: 0
Study 35956389 — intervention group
Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 0
Study 34320390 — intervention group
Group type: EXPERIMENTAL
Intervention: BNT162b2 vaccine-elicited human sera
Number of subjects: 215
Study 34320390 — intervention group
Group type: COMPARATOR
Intervention: Convalescent wild-type infected serums
Number of subjects: 215
Study 34320390 — intervention group
Group type: COMPARATOR
Intervention: Convalescent P.1 patients
Number of subjects: 215
Study 35790316 — intervention group
Group type: EXPERIMENTAL
Intervention: Home-based inspiratory muscle training (IMT) programme for 12 weeks
Number of subjects: 26
Study 35790316 — intervention group
Group type: COMPARATOR
Intervention: Usual care alone
Number of subjects: 26
Study 33618029 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.1% Cys fortification in low-CP diet
Number of subjects: 432
Study 33618029 — intervention group
Group type: COMPARATOR
Intervention: Normal-CP diet (positive control)
Number of subjects: 432
Study 33618029 — intervention group
Group type: COMPARATOR
Intervention: Low-CP diet (negative control)
Number of subjects: 432
Study 33618029 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.05%, 0.1%, 0.15%, 0.2% Cys fortification in low-CP diet
Number of subjects: 432
Study 32428202 — intervention group
Group type: EXPERIMENTAL
Intervention: Hospital at Home (HAH)
Number of subjects: 34
Study 32428202 — intervention group
Group type: COMPARATOR
Intervention: Hospital inpatient care
Number of subjects: 34
Study 35551149 — intervention group
Group type: EXPERIMENTAL
Intervention: Dolutegravir + Rilpivirine
Number of subjects: 1021
Study 35551149 — intervention group
Group type: COMPARATOR
Intervention: Current Antiretroviral Regimen (CAR)
Number of subjects: 1021
Study 33901868 — intervention group
Group type: EXPERIMENTAL
Intervention: Axitinib
Number of subjects: 0
Study 33901868 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 33336508 — intervention group
Group type: EXPERIMENTAL
Intervention: 1% (w/w) GSK2646264
Number of subjects: 11
Study 33336508 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 11
Study 32897372 — intervention group
Group type: EXPERIMENTAL
Intervention: PREVENT QI intervention (multicomponent intervention including clinical programs, data feedback, professional education, electronic health record tools, and QI support)
Number of subjects: 1135
Study 32897372 — intervention group
Group type: COMPARATOR
Intervention: Matched control sites (no intervention)
Number of subjects: 1135
Study 33508224 — intervention group
Group type: EXPERIMENTAL
Intervention: 3HP (isoniazid and rifapentine) for 12 weeks
Number of subjects: 2923
Study 33508224 — intervention group
Group type: COMPARATOR
Intervention: No treatment (3HP negative)
Number of subjects: 2923
Study 33508224 — intervention group
Group type: EXPERIMENTAL
Intervention: RISK11-positive participants
Number of subjects: 2923
Study 33508224 — intervention group
Group type: COMPARATOR
Intervention: RISK11-negative participants
Number of subjects: 2923
Study 33222989 — intervention group
Group type: EXPERIMENTAL
Intervention: Team handball group (THG, n = 41)
Number of subjects: 67
Study 33222989 — intervention group
Group type: COMPARATOR
Intervention: Control group (CG, n = 26)
Number of subjects: 67
Study 35660103 — intervention group
Group type: EXPERIMENTAL
Intervention: Repetitive neuromuscular magnetic stimulation (rNMS) targeting the upper trapezius muscles (UTM)
Number of subjects: 33
Study 36128500 — intervention group
Group type: EXPERIMENTAL
Intervention: Platelet-rich plasma and hyaluronic acid after arthroscopic joint debridement
Number of subjects: 126
Study 36128500 — intervention group
Group type: COMPARATOR
Intervention: Arthroscopic joint debridement
Number of subjects: 126
Study 34291957 — intervention group
Group type: EXPERIMENTAL
Intervention: Web-based alcohol intervention including strategies to reduce drinking and improve regulatory skills
Number of subjects: 200
Study 34291957 — intervention group
Group type: EXPERIMENTAL
Intervention: Web-based alcohol intervention
Number of subjects: 200
Study 34291957 — intervention group
Group type: COMPARATOR
Intervention: Assessment-only control
Number of subjects: 200
Study 35960871 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral azacitidine (Oral‐AZA) 300 mg
Number of subjects: 472
Study 35960871 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 472
Study 33462358 — intervention group
Group type: EXPERIMENTAL
Intervention: Liraglutide 3.0 mg
Number of subjects: 0
Study 33462358 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 35013351 — intervention group
Group type: EXPERIMENTAL
Intervention: BioFire FilmArray Pneumonia panel plus (FAP plus)
Number of subjects: 104
Study 35013351 — intervention group
Group type: COMPARATOR
Intervention: Standard diagnostic methods (SDs)
Number of subjects: 104
Study 34158088 — intervention group
Group type: EXPERIMENTAL
Intervention: 4 × 4 cm onlay mesh
Number of subjects: 288
Study 34158088 — intervention group
Group type: COMPARATOR
Intervention: Conventional suture repair
Number of subjects: 288
Study 34586357 — intervention group
Group type: EXPERIMENTAL
Intervention: Pain Reprocessing Therapy (PRT)
Number of subjects: 151
Study 34586357 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 151
Study 34586357 — intervention group
Group type: COMPARATOR
Intervention: Usual Care
Number of subjects: 151
Study 33865865 — intervention group
Group type: EXPERIMENTAL
Intervention: CRT-P (pacemaker)
Number of subjects: 0
Study 33865865 — intervention group
Group type: EXPERIMENTAL
Intervention: CRT-D (combined pacemaker-defibrillator)
Number of subjects: 0
Study 32240228 — intervention group
Group type: COMPARATOR
Intervention: Foot massager
Number of subjects: 28
Study 32240228 — intervention group
Group type: COMPARATOR
Intervention: Heat therapy
Number of subjects: 28
Study 32240228 — intervention group
Group type: EXPERIMENTAL
Intervention: Foot massager plus heat therapy
Number of subjects: 28
Study 32240228 — intervention group
Group type: EXPERIMENTAL
Intervention: No active intervention
Number of subjects: 28
Study 32833539 — intervention group
Group type: EXPERIMENTAL
Intervention: Minoxidil + Concentrated Growth Factors (CGF)
Number of subjects: 16
Study 32833539 — intervention group
Group type: COMPARATOR
Intervention: Minoxidil
Number of subjects: 16
Study 34289839 — intervention group
Group type: EXPERIMENTAL
Intervention: Face to face counseling intervention (AMI)
Number of subjects: 331
Study 34289839 — intervention group
Group type: COMPARATOR
Intervention: Peer-facilitated health campaign (three oral health fairs)
Number of subjects: 331
Study 33280667 — intervention group
Group type: EXPERIMENTAL
Intervention: Plant cultivating program conducted for six weeks
Number of subjects: 80
Study 33280667 — intervention group
Group type: EXPERIMENTAL
Intervention: Plant cultivating program
Number of subjects: 80
Study 36113534 — intervention group
Group type: EXPERIMENTAL
Intervention: ShangRing
Number of subjects: 1378
Study 36113534 — intervention group
Group type: COMPARATOR
Intervention: Mogen clamp
Number of subjects: 1378
Study 35003318 — intervention group
Group type: EXPERIMENTAL
Intervention: Massive transfusion protocol
Number of subjects: 94
Study 35003318 — intervention group
Group type: COMPARATOR
Intervention: Routine transfusion protocol
Number of subjects: 94
Study 32569678 — intervention group
Group type: EXPERIMENTAL
Intervention: 46 µg/day TMG
Number of subjects: 80
Study 32569678 — intervention group
Group type: EXPERIMENTAL
Intervention: 94 µg/day TMG
Number of subjects: 80
Study 32569678 — intervention group
Group type: EXPERIMENTAL
Intervention: 147 µg/day TMG
Number of subjects: 80
Study 32569678 — intervention group
Group type: EXPERIMENTAL
Intervention: 184 µg/day TMG
Number of subjects: 80
Study 34024220 — intervention group
Group type: EXPERIMENTAL
Intervention: Extracellular vesicles (EVs) in prostate cancer (PCa) patients
Number of subjects: 16
Study 34024220 — intervention group
Group type: EXPERIMENTAL
Intervention: Extracellular vesicles (EVs) in newly diagnosed PCa patients
Number of subjects: 16
Study 33819140 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous unfractionated heparin started 12 hours postoperatively at 10 UI/kg per hour
Number of subjects: 365
Study 33819140 — intervention group
Group type: COMPARATOR
Intervention: No heparin treatment
Number of subjects: 365
Study 33819140 — intervention group
Group type: EXPERIMENTAL
Intervention: Heparin prophylaxis
Number of subjects: 365
Study 35236099 — intervention group
Group type: EXPERIMENTAL
Intervention: Omecamtiv mecarbil
Number of subjects: 0
Study 35236099 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 35992545 — intervention group
Group type: EXPERIMENTAL
Intervention: Remazolam combined with etomidate
Number of subjects: 100
Study 35992545 — intervention group
Group type: COMPARATOR
Intervention: Etomidate (single-drug group)
Number of subjects: 100
Study 35867146 — intervention group
Group type: EXPERIMENTAL
Intervention: Outpatient monitoring of IOP with self-tonometry for 7 days
Number of subjects: 1980
Study 35867146 — intervention group
Group type: COMPARATOR
Intervention: Inpatient monitoring of IOP for 24 hours
Number of subjects: 1980
Study 32498426 — intervention group
Group type: EXPERIMENTAL
Intervention: Test product (AA mixture engineered to prolong AA absorption with Physiomimic TechnologyTM)
Number of subjects: 30
Study 32498426 — intervention group
Group type: COMPARATOR
Intervention: Reference product (free AA mixture)
Number of subjects: 30
Study 616760951 — intervention group
Group type: EXPERIMENTAL
Intervention: Resident Assessment Instrument (RAI) implemented intensively
Number of subjects: 0
Study 616760951 — intervention group
Group type: COMPARATOR
Intervention: Resident Assessment Instrument (RAI) not implemented intensively
Number of subjects: 0
Study 35470085 — intervention group
Group type: EXPERIMENTAL
Intervention: Half-dose photodynamic therapy (PDT) for 12 weeks
Number of subjects: 49
Study 35470085 — intervention group
Group type: COMPARATOR
Intervention: Eplerenone for 12 weeks
Number of subjects: 49
Study 35470085 — intervention group
Group type: EXPERIMENTAL
Intervention: Half-dose photodynamic therapy (PDT)
Number of subjects: 49
Study 35470085 — intervention group
Group type: COMPARATOR
Intervention: Eplerenone
Number of subjects: 49
Study 33471164 — intervention group
Group type: EXPERIMENTAL
Intervention: Shock Wave Lithotripsy (SWL)
Number of subjects: 108
Study 33471164 — intervention group
Group type: COMPARATOR
Intervention: Laser Ureteroscopy (URS)
Number of subjects: 108
Study 32246432 — intervention group
Group type: EXPERIMENTAL
Intervention: Caregiver FACT-G
Number of subjects: 747